好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

2019 Annual Meeting | C225 - Actualización científica II (Scientific Update II)

Thursday 05/09/19
01:00 PM - 03:00 PM EDT Add To Calendar
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
Seminar
Alejandro Tobon, MD, FAAN
General Neurology
Los participantes tendrán un mayor conocimiento de los últimos avances científicos en el diagnóstico y manejo de enfermedades neuromusculares, epilepsia y esclerosis múltiple.
2.00 CME credits
Patient Care & Procedural Skills, Medical Knowledge, Practice-based Learning and Improvement, Systems-based Practice
Intermediate
Spanish Language
Fellow, Resident, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student
Didactic

Program Materials Program Evaluations

Event Timeline
01:00 PM - 01:30 PM EDT Speaker Enfermedades neuromusculares
Alejandro Tobon, MD, FAAN
01:30 PM - 02:00 PM EDT Speaker Esclerosis Múltiple
Daniel Ontaneda, MD, PhD, FAAN
02:00 PM - 02:30 PM EDT Speaker Epilepsia
Luis C. Mayor-Romero, MD
02:30 PM - 03:00 PM EDT Q&A Preguntas y discusión
Faculty Disclosures
Alejandro Tobon, MD, FAAN Dr. Tobon has nothing to disclose.
Luis C. Mayor-Romero, MD Dr. Mayor-Romero has nothing to disclose.
Daniel Ontaneda, MD, PhD, FAAN Dr. Ontaneda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Ontaneda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech/Roche. Dr. Ontaneda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen Idec. Dr. Ontaneda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. The institution of Dr. Ontaneda has received research support from NIH. The institution of Dr. Ontaneda has received research support from PCORI. The institution of Dr. Ontaneda has received research support from NMSS. The institution of Dr. Ontaneda has received research support from Genetech.